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Abstract 
Using the baculovirus ystem, the skeletal muscle chloride channel, ClC-l (rat), and a point mutant replacing arginine 304 with 
glutamic acid were expressed at high levels in cultured Sf-9 insect cells. Whole-cell patch-clamping revealed large inwardly rectifying 
currents with maxima up to 15 nA inward and 2.5 nA outward. Saturation was evident at voltage steps positive to +40 mV whilst steps 
negative to -60  mV produced inactivating currents made up of a steady state component and two exponentially decaying components 
with z I = 6.14_+0.92 ms, z 2 = 36.5_+ 3.29 ms (S.D.) n = 7 for steps to -120 mV. Currents recorded in the outside-out patch 
configuration were often unexpectedly large and up to 5% of whole-cell currents obtained in the same cell, suggesting an uneven channel 
distribution in the plasmalemma of Sf-9 cells. The pharmacology of a number of chloride channel blockers, including anthracene-9- 
carboxylate (A9C), niflumate, and perrhenate, was investigated and showed for the first time that perrhenate is an effective blocker of 
CIC-I and that it has a complex mechanism of action. Further, the potency of A9C was found to be dependent on external chloride 
concentration. As in studies on muscle cells themselves, blockade was rapidly effective and easily reversible, except when applying the 
indanyloxyacetate derivative, IAA94/95, which took up to 10 rain to act, and, consistent with an intracellular site of action, was difficult 
to reverse by washing. Mutation of the highly conserved arginine at position 304 to a glutamic acid did not significantly alter the 
behaviour of the channel. 
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1. Introduction 
Chloride channels of the CIC family have now been 
demonstrated in many cell types where they have been 
implicated in a variety of functions including volume 
regulation [1], ion secretion [2], ion balance [3] and stabili- 
sation of membrane potential [4]. Within this family, the 
C1C-I type is expressed primarily in skeletal muscle [4] 
and there is a very high level of homology between 
different species (rat, mouse and human). Normal function 
of these channels is essential for the control of excitability 
in skeletal muscle, mutations in C1C-1 having been linked 
to the muscle hyperexcitability diseases, Thomsen's auto- 
somal dominant myotonia congenita and Becker's reces- 
sive generalised myotonia, [5-8]. 
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Complementary DNAs encoding the rat and human 
CIC-I protein have previously been successfully expressed 
in Xenopus oocytes [4], HEK293 [9] and COS cells [4]. 
Currents through the expressed CIC-1 channels have been 
observed in the former two cell types and are characterised 
by inactivation at hyperpolarising potentials and saturation 
at depolarising potentials, in accordance with macroscopic 
currents seen in muscle cells. Expression of cDNA incor- 
porating the point mutations found in human pedigrees 
leads to abnormal currents further supporting the con- 
tention that CIC-I is the channel defective in the above- 
mentioned diseases [4]. Interestingly, the kinetics of the 
currents recorded differ for channels expressed in oocytes 
and HEK cells [4,9]. 
In the present work, wild-type rat CIC-1 and a point 
mutant (glutamic acid replacing arginine at position 304) 
were expressed at high levels in cultured insect cells using 
a baculovirus vector (cf. [10] and [4]). Whole-cell patch- 
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clamping was used directly on Sf-9 cells expressing the 
CIC-1 proteins, revealing macroscopic urrents typical of 
those found in other heterologous expression systems and 
quite comparable with those recorded from muscle cells. 
Similar results are presented for the first time using the 
outside-out patch configuration. Patch longevity and stabil- 
ity has been a feature of our study allowing excellent 
freedom from current drift and ready ability to return to 
control conditions following tests. Characteristics of chlo- 
ride currents in Sf-9 cells were compared with those 
observed in other rectifying channels and susceptibility to 
various chloride channel blocking compounds was as- 
sessed. We show that these blockers have characteristic 
and differential actions on instantaneous and steady state 
currents. Evidence is also presented for heterogeneous 
distribution of C1C-I in the Sf-9 plasmalemma. 
2. Materials and methods 
2.1. Protein expression 
The original clc-1 cDNA in vector pBluescript (Strata- 
gene) [4] was provided by Professor Thomas Jentsch and 
Dr. Kalus Steinmeyer of the Centre for Molecular Neuro- 
biology, Hamburg, Germany and was designated, in our 
laboratory, TJJClone. Insert cDNA was excised with XbaI 
and ClaI, end-filled using Klenow DNA polymerase and 
blunt end ligated into BamHI cleaved, end filled bac- 
ulovirus transfer vector pBacPAK1 (Clonetech). Clones 
were isolated containing insert DNA in forward and re- 
verse orientations which were designated pDA1BVR and 
pDA2BVR, respectively. Insert DNA in pDAIBVR was 
subjected to PCR using primers (CLCXBA, CLCTTH) 
designed to amplify the region of the open reading frame 
from the start codon (nt 84) to 30 bp downstream of the 
unique Tthl l l I  site (nt 387). Upstream primer CLCXBA 
was designed to remove the upstream untranslated region 
whilst incorporating an XbaI site immediately prior to the 
ATG. PCR products were separated from unincorporated 
primers, nucleotides and target DNA by electrophoresis on
a 1% TAE agarose gel. The product band was then excised 
and extracted using Qiaex resin (QIAGEN), cleaved with 
XbaI and Tthl l l I  and ligated into similarly cleaved and 
purified TJJClone. Modified clc-1 in its entirety was then 
excised from pBluescript using XbaI and KpnI, gel puri- 
fied and ligated into similarly cleaved pBacPAK8 (Clone- 
tech). This third construct was designated pDA6bvr. Orien- 
tation of the insert DNA and integrity of all constructs was 
established by restriction analysis and DNA sequencing 
(double stranded ye-labelled terminator method, Applied 
Biosystems, primers Bacl (PBPRIMI)  and Bac2 
(PBPRIM2) for pDA 1BVR and pDA2BVR, PBPRIM 1 and 
TTHSEQ for pDA6BVR). 
Recombinant baculoviruses were produced in IPLB-Sf- 
21 insect cells grown in Grace's insect cell culture medium 
(Gibco) supplemented with lactalbumin hydrolysate, yeast- 
olate (Difco) and 10% bovine fetal serum (CSL). Mono- 
layer cultures of insect cells were incubated at 28-30°C in 
air and passaged at ca. 80% confluence (twice weekly). 
Cells to be infected were seeded at low density (40-50% 
confluence) and incubated overnight before inoculation. 
Each vector was introduced into the Sf-21 cells along with 
linearised baculovirus (Bac6, Clonetech, cf. [11]) using 
lipofectin (Gibco BRL) mediated transformation asrecom- 
mended by the supplier. After 2 days incubation, the 
culture supernatants were collected and used to produce 
isolated plaques in Sf-21 monolayers following the method 
described by King and Possee [12]. Four clones derived 
from each of the three constructs were used to infect fresh 
Sf-21 monolayers. Following incubation (5-7 days) the 
cells were collected, washed in PBS (Dulbecco A, Oxoid) 
and virus DNA extracted as described by King and Possee 
[12]. PCR using the Bacl and 2 sequencing primers was 
used to confirm transfer of the relevant insert DNA into 
the viral genome in all clones and restriction analysis of 
PCR products using EcoRV and Tthl l lI confirmed the 
predicted orientation of the tic-1 reading frame with re- 
spect to the polyhedrin promoter. Four clones of each 
recombinant virus were amplified by infection of Sf-21 
monolayers in 25 cm flasks. Resulting virus stocks were 
titred by standard plaque assay [12] and were then screened 
for protein production in Sf-9 insect cells (chosen for their 
amenability to electrophysiological study [10]) cultured as 
for the Sf-21 cells and treated as follows. Sf-9 cells in 35 
mm dishes were infected with each clone at a multiplicity 
of infection (moi) of 60-100 and incubated for 48 h. Cells 
were then harvested, washed and resuspended in PBS to a 
concentration of 104 cells//,,l. Following sonication in a 
bath type sonicator, an equal volume of 2 × PAGE sample 
buffer (100 mM Tris-Cl, 200 mM dithiothreitol, 4% SDS, 
0.2% bromophenol blue, 20% glycerol (pH 6.8)) was 
added. Samples (15/,~1) were electrophoresed on discontin- 
uous polyacrylamide gels [13] (4% stacking gel, 9% re- 
solving gel). Proteins were visualised by staining for 30 
rain in coomassie blue followed by overnight destaining. 
After analysis of protein expression, one clone of each 
recombinant virus was selected for use in further experi- 
ments, designated BVDAI (complete cDNA forward ori- 
entation), BVDA2 (complete cDNA reverse orientation) 
and BVDA6 (5' UTR deleted). Putative glycosylation of 
the expressed protein was assessed using the glycosylation 
inhibitor, tunicamycin (Boehringer Mannheim) as de- 
scribed by King and Possee [12]. 
Large scale working stocks of virus clones BVDA2 and 
BVDA6 were produced by infection of 50 ml suspension 
cultures of Sf-21 cells with each virus at 0.2 moi. Cultures 
were harvested after 6-7 days incubation and the cells 
removed by centrifugation (3000 × g~ 10 min). Virus-con- 
taining supernatants were stored at 4°C. Titres of working 
stocks were determined using standard plaque assay. 
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2.2. Site-directed mutagenesis 
5' modified cDNA was excised from pDA6BVR and 
subcloned into vector pALTER-1 (Promega) using BamHI 
and KpnI. Mutagenesis of the arginine residue at position 
304 to glutamic acid was performed using the Altered 
Sites System (Promega) following the manufacturers pro- 
tocols and using mutagenic primer JCR304E. The primer 
serves to change the arginine codon TCG to TTC and 
eliminates an MnlI restriction site. Verification of mutants 
was by PCR of the sequence spanning codons 272 to 393 
using primers JCSEQ1 and JCSEQ2 followed by direct 
sequencing, using the same primers (Applied Biosystems, 
dyelabelled terminator protocol) and restriction analysis 
using MnlI. Mutated cDNA was then excised from pAL- 
TER-1 using XbaI and KpnI and subcloned into pBac- 
PAK8 to produce pDA6-R304E. Virus production and 
verification was as described above finally resulting in 
baculovirus expression vector BVDA6-R304E. 
2.3. Oligonucleotide primer sequences 
CLCTTH 5'-TCCTT CTCAG CACAC GTCCC AG- 
GCG AT-3'; CLCXBA 5'-ATTCT AGATG GAGCG 
GTCCC AGTCC CAG-3'; JCR304 5'-GGAAT TACTG 
GGAGG GATTC TTTGC-3'; JCSEQ1 5'-GCCGT 
GGGGG GTCGG TTGCT GT-3'; JCSEQ2 5'-ATAGA 
GCAGG CGGTG CTTAG C-3'; PBPRIM1 5'-ACCAT 
CTCGC AAATA AATAA G-3'; PBPRIM2 5'-ACAAC 
GCACA GAATC TAGCG-3'; TTHSEQ 5'-GCTAA 
CATAG TCCAT GCACC A-3'. 
pCLAMP v5.5 software (Axon Instruments) which also 
enabled such analysis as extraction of exponential and 
steady state components from original current records. 
Potentials listed are pipette potentials corresponding to the 
convention, intracellular potential relative to outside zero. 
Junction potentials estimated to be -14  mV between 
standard pipette and bath solutions were not corrected for, 
unless otherwise stated, in the presentation of our results. 
Experiments were performed at room temperatures of 21 
___ I°C. In conductance blocking experiments, anthracene- 
9-carboxylate (A9C, Aldrich), perrhenate (Koch-Light), 
2,4-dichlorophenoxyacetate (2,4-D, Sigma), an indany- 
loxyacetate derivative (IAA94/95 from D.W. Landry, see 
[14]) and niflumate (Squibb) were prepared as the sodium 
salts from their corresponding acids, by neutralisation with 
an equivalent amount of NaOH (1 M), allowing ready 
aqueous dissolution. Dose-response curves were fitted 
using the sigmoidal dose-response (variable slope) func- 
tion of GraphPad Prism (GraphPad Software Inc., San 
Diego, CA). In some experiments, NaC1 in the bath solu- 
tion was replaced by glucose on an equi-osmolar basis and, 
in others, all cations except for H + in either or both the 
bath and pipette were replaced by Tris. When iodide was 
used as the blocker, NaI replaced NaC! on an equimolar 
basis in the bath solution. Under the conditions employed 
in the present study, background conductance of the Sf-9 
cell membrane was relatively low (cf. [15]). Where neces- 
sary, pentobarbitone (Faulding, 0.5 mM) was used to block 
native anion channels [15], which allowed them to be 
readily discriminated from expressed channels. 
2.4. Electrophysiology 3. Results 
Sf-9 insect cells were seeded at low density in 35 mm 
petri dishes and incubated, as described for Sf-21 cells, 
until ca. 50% confluence (24-48 h). Cells were then 
infected with virus clones BVDA2, BVDA6 or BVDA6- 
R304E at a moi of 50 and incubated for 24-30 h. Follow- 
ing incubation, infected cells were seeded onto glass cov- 
erslips and, until used for patch-clamping, were maintained 
at room temperature in cell culture medium for up to 10 h. 
Immediately prior to patch-clamping, cells were rinsed in 
bath solution to remove excess culture medium. The bath 
solution contained (mM) NaC1 (160), MgC12 (2), CaC12 
(2), glucose (10) and Hepes-Na (10) at pH 7.4. For low 
chloride bath solution (4 mM) NaCI was replaced by 
Na-glutamate and MgCI 2 was replaced by MgSO 4. 
Whole-cell and outside-out patch-clamping was performed 
directly on cells 28-34 h post infection using a List EPC7 
patch clamp amplifier and associated standard patch- 
clamping equipment. Electrodes of 2-4 M ~ were pulled 
from borosilicate glass on a Kopf two step puller and were 
filled with a solution containing (mM) KCI (40), K- 
glutamate (120), EGTA-Na (10) and Hepes-Na (10) at pH 
7.2. Data were collected using an IBM compatible PC and 
3.1. Protein expression 
PAGE analysis of Sf-9 cells revealed a clearly visible 
protein band with an apparent M r of ca. 116 kDa (Fig. 1) 
which was present only in cells infected with virus clones 
expected to express C1C-1 (BVDAI, BVDA6, BVDA6- 
R304E). Cells infected with virus clones not anticipated to 
express C1C-1 (BVDA2) did not produce the 116 kDa 
protein but otherwise showed a protein profile similar to 
that seen in other infected cells and different from unin- 
fected cells. Similarly, the 116 kDa protein was not de- 
tectable in cells infected with wild type AcMNPV control 
virus (results not shown). Although all BVDA1 and 
BVDA6 (wt and mutant) clones expressed the 116 kDa 
protein, the level of expression varied. One clone of each 
type was selected at random from those clones giving the 
best expression. A consistently and markedly higher yield 
of CIC-1 was obtained in cells infected with BVDA6 (wt 
and mutant, 5' UTR deleted) compared to BVDA1 (Fig. 
1). Investigation of post translational processing using the 
glycosylation inhibitor tunicamycin failed to reduce the 
apparent M r of the protein. Harvesting of cells at various 
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Fig. 1. A Coomassie blue stained 9% SDS-PAGE of whole cell protein 
extracts from Sf-9 cells at 40 h post infection. Extracts made from a 
standardised number of cells were applied to each lane. Lane 1: unin- 
fected cells. Lane 2: infected with negative control virus (BVDA2.1). 
Lane 3: infected with virus containing complete tic-1 cDNA (BVDAI.7). 
Lane 4: infected with virus containing clc-1 cDNA with 5' untranslated 
sequence deleted (BVDA6.3). Molecular weight markers (kDa) are indi- 
cated. Lanes 3 and 4 show expression f a protein at an apparent Mr of 
116 kDa. 
time points, from 18-170 h pi, showed that C1C-1 was 
detectable by coomassie staining from approximately 30 h 
pi, with maximum expression at around 40 h. After ca. 72 
h incubation, protein yield decreased rapidly concomitant 
with virus-induced host cell lysis. 
3.2. E lect rophys io logy  
Gigaohm seals were easily obtained on Sf-9 cells, 
whether infected or uninfected, in standard bath solution. 
In the cell-attached patch, resistance was always high 
(> 10 GO)  and no voltage-dependent si gle channel activ- 
ity was observed. Nor was there any obvious conductance 
nonlinearity that might have indicated voltage-dependent 
activity of channels with a conductance too small to be 
resolved at the single channel level. 
Whole-cell mode was achieved from cell-attached 
patches by the application of negative pressure to the 
pipette and could regularly be maintained for an hour or 
more. Evaluation of control cells (uninfected and BVDA2 
infected) then revealed small whole-cell eakage currents, 
constant with time and almost linear with respect o volt- 
age (Fig. 2), that could be evoked by the voltage step 
protocol illustrated. Maximum currents were typically in 
the range of 150 pA inward and outward. Under certain 
conditions, such as hypotonicity, larger currents were able 
to be induced which could be attributed to the activity of 
native volume regulatory anion channels. This activity was 
readily blocked by pentobarbitone, l aving the above-men- 
tioned low amplitude leakage currents. In contrast, cells 
infected with BVDA6 (wt and mutant) and expressing 
C1C-1, produced large inwardly rectifying currents with 
maxima up to 15 nA inward and 2.5 nA outward (Fig. 2) 
that were unaffected by pentobarbitone ( > 10 mM). These 
inwardly rectifying currents had a reversal potential of 
- 23.9 ___ 1.4 mV (S.D., n = 25) which, when corrected for 
a junction potential of - 14 mV, was close to that calcu- 
lated from the Nernst equation ( -36 .6  mV) for the im- 
posed chloride gradient. Deactivation of peak inward cur- 
rent to a steady state was evident for potential steps 
negative to - 60 mV whilst saturation of outward currents 
a 1 100m s +80m V OOm s 
-30 m V 
-120mV 
b 
l ¢ 
c t 
d 
e 
I 
d 
L 
2000 pA  
I 20ms 
Fig. 2. Whole-cell patch-clamp currents due to expressed C1C-1 in a 
cultured Sf-9 insect cell. (a) Voltage step protocol: aholding potential of
-30 mV was maintained for at least 2 s between pulses comprising an 
activating prepulse to+40 mV for 100 ms followed in each cycle by 100 
ms test pulses ranging from - 120 to + 80 mV in 20 mV increments. (b)
Currents elicited by the voltage step protocol (illustrated in a) in an Sf-9 
cell not expressing CIC-1, having been infected with negative control 
virus (BVDA2.1). (c) Currents (as in b) but elicited in an Sf-9 cell 
expressing CIC-1, having been infected with virus containing clc-1 
cDNA with 5' untranslated sequence deleted (BVDA6.3). (d) Currents 
from the same cell (as in c) after addition of perrhenate (10 raM) to the 
bath solution. (e) Restoration f currents, again in the same cell (as in c), 
5 min after washout with normal bath solution. 
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was observed for steps more positive than +40 inV. 
Maximal inward current was obtained by activation of 
channels using a 100 ms prepulse to +40 mV prior to 
each step in the voltage protocol. Neither deactivation nor 
saturation of outward currents were significantly modified 
by bathing solutions or pipette solutions in which all small 
cations other than H ÷ were substituted by Tris. Higher 
Ca 2÷ or Mg 2+ concentrations of up to 20 mM in the 
bathing solution or up to 2 mM in the pipette were, 
likewise, without significant effect. 
Fig. 3 shows the I -V  relationship for both the instanta- 
neous and steady state currents illustrated in Fig. 2. The 
deactivating inward currents (Fig. 2) evoked by strongly 
hyperpolarising voltage steps are made up of three readily 
resolvable components, two decreasing exponentially, plus 
a steady state component. Kinetic behaviour of deactivat- 
ing currents in the R304E mutant was not noticeably 
different from wild-type where pulses to - 120 mV elicited 
exponentially decaying components with time constants 
~'l = 6.14 _ 0.92 and ~'2 = 36.5 + 3.29 ms (S.D., n = 7). 
For lesser hyperpolarisations the fast component becomes 
even faster and the slow becomes slower, e.g., at -60  
mV, ~'1 = 2.8 + 0.53 and ~'2 = 94.6 ± 23.7 ms (S.D., n = 7) 
until, eventually, they become unresolvable as they merge 
with the capacitive transient and the steady state current, 
respectively, for still less negative pulses. Some drift in the 
characteristics of these currents was noted in the first 20 
min after perforation of the patch to enter the whole-cell 
recording mode. Peak and steady state currents steadily 
increased and kinetics slowed slightly, mainly as a result 
of an increased prominence of the second component. By 
20 to 30 min post perforation, excellent stability was 
achieved with little or no further drift in any observed 
current parameter. When very long lasting (seconds) hy- 
perpolarising pulses were used, a third exponential with a 
Voltage (mY) 
J- J- I ' ¢ i ,{ ,  ~'20 -100 -80 -~9"  -20 
C -10 
~o Xo 6'0 8'o 
.¢.9 
Fig. 3. Current-voltage curves from control Sf-9 cells and cells express- 
ing CIC-I. Sets of whole-cell currents, as illustrated in Fig. 2c, were used 
to produce current-voltage curves from (a) a typical Sf-9 cell infected 
with negative control virus (BVDA2.1) compared with steady state (b) 
and peak (c) currents obtained from a different cell infected with virus 
containing clc-1 cDNA with 5' untranslated sequence deleted (BVDA6.3). 
10 20 ms 
pA 
Fig. 4. Outside-out patch-clamp currents due to expressed CIC-I in a 
cultured Sf-9 insect cell. Currents were elicited by the step protocol 
illustrated in Fig. 2a. The peak inward current of approx. 70 pA for the 
-120 mV step was obtained from an Sf-9 cell which had a maximum 
whole-cell inward current of approx. 1.5 nA for the same hyperpolarising 
step. 
time constant of the order of several hundred milliseconds 
could be extracted from the deactivating currents. 
Outside-out patches could, in many cases, be obtained 
by pulling the pipette away from a cell in which whole-cell 
recording had been established. From control cells, out- 
side-out patches occasionally showed single channel activ- 
ity that was not voltage-dependent and which could be 
blocked by pentobarbitone, Large voltage-dependent cur- 
rents were only ever seen in outside-out patches from 
appropriately infected cells which had previously dis- 
played similar macroscopic currents in the whole-cell patch. 
Peak amplitudes of the deactivating currents varied consid- 
erably from patch to patch but in 10% of positive patches 
(n > 40) were as much as 5% of the original whole-cell 
current amplitude (Fig. 4) despite microscopic observation 
showing no evidence of tethers, no visible vesicle at the 
pipette tip and predicted surface area having diminished to 
much less than 1% of that of the whole-cell [16]. Kinetics 
were as described for whole-cell currents. Interestingly, 
there was sometimes an increase of up to two times in 
current amplitude during the first few minutes following 
formation of the outside-out patch after which all current 
parameters were stable. No discrete current steps indicative 
of single channel events, other than those that could be 
attributed to the native anion channels, were ever seen in 
these patches. 
Known blockers of chloride conductance in whole mus- 
cle preparations, uch as perrhenate (Fig. 2), A9C (Fig. 5), 
2,4-D and iodide (results not shown) reduced inward and 
outward currents in both whole-cell and outside-out patch 
configurations toward levels seen in control cells. When 
perrhenate was applied, block of instantaneous currents 
was simply proportionally related to concentration (Fig. 
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Fig. 5. Whole-cell patch-clamp currents, elicited by the same voltage 
protocol as in Fig. 2a, showing the effects of chloride channel blockers. 
(a) Currents elicited in an Sf-9 cell expressing CIC-1. (b) Currents from 
the same cell 5 min after addition of A9C (0.1 mM) to the bath. (c) 
Restoration of currents, again in the same cell, 10 min after washout with 
normal bath solution. (d,e,f) A similar sequence of patch-clamp currents 
illustrating blocking action by niflumate (1 raM) and subsequent washout. 
6a), but steady state currents appear to be increased by 
concentrations of  about 1 mM and decreased by higher 
concentrations ( ee also Fig. 6c). By contrast, A9C always 
appears to block both instantaneous and steady state cur- 
rents to similarly increasing extents with increasing con- 
centration (Fig. 6b). Dose- response  curves for the block- 
ing action of  perrhenate and A9C are illustrated in Fig. 6c, 
where the calculated IC50 for instantaneous currents is 1.1 
mM and 7 /,tM, respectively. The potency of  A9C was 
found to be markedly increased when using low external 
chloride concentrations. When applied in bath solution 
containing 4 mM C I -  the same changes in current ampli- 
tudes occurred at lower concentrations and the calculated 
IC50 was reduced to 1.6 /xM (Fig. 6c). Prel iminary results 
with niflumate, a potent blocker of red cell anion ex- 
change, indicate that it reduces currents in a similar fash- 
ion to A9C (Fig. 5) with an ICs0 of 50 /zM. All of  these 
blockers were rapidly effective (within seconds, as bath 
solution was exchanged) and were totally reversible on 
washout. When high concentrations (mM) of  another chlo- 
ride conductance blocker, IAA94/95 ,  were applied, at 
least 10 min elapsed before block became apparent, and 
reversal was difficult to obtain, even with extensive wash- 
ing. Potency and characteristics of block by these various 
agents was not different in the R304E mutant. 
4. D iscuss ion  
The CIC-1 protein is expressed at high levels in the 
baculovirus-Sf-9 insect cell system. Expression of  this 
channel using cRNA injection in Xenopus oocytes has 
previously been found to require the replacement of  the 5' 
untranslated region of  the message with the equivalent 
region of  the C1C-0 channel from Torpedo californica [4]. 
In Sf-9 cells, the channel is expressed without modif ication 
of the message although the level of  expression is signifi- 
cantly enhanced by the complete removal of  the upstream 
untranslated sequence. Previous studies of  expression of  
foreign genes using the baculovirus polyhedrin promoter 
a 
b 
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Fig. 6. Dose-response r lationships for the blocking action of perrhenate 
and A9C. (a) Effect of blocking doses of perrhenate ranging from 10 /~M 
to 10 mM on whole-cell currents elicited by a 100 ms voltage test pulse 
to - 120 mV immediately following a 100 ms prepulse to + 40 mV (part 
of the voltage step protocol shown in Fig. 2a). Each current is shown as 
the sum of its steady-state and fast and slow exponential components and 
represents he line of best fit to the original current record. All currents 
were recorded from the one whole cell patch on a single cell, allowing 
sufficient ime for equilibration of the response at each new concentra- 
tion. (b) Whole-cell currents, represented as in (a), in the presence of 
blocking doses of A9C ranging from 0.1 /xM to 1 raM. Again allowing 
time for equilibration, all currents were recorded from the one whole-cell 
patch on a single cell. (c) Dose-response curves for the blocking action 
of A9C (168 mM chloride, filled triangles; 4 mM chloride, open trian- 
gles) and perrhenate (filled circles) on normalised peak instantaneous 
currents. Current amplitudes were determined from summation of ex- 
tracted components, as in (a), extrapolated back to the beginning of the 
test pulse. Solid lines represent sigmoidal dose-response functions fitted 
as described in Section 2. The dose-response curve for the blocking 
effect of perrhenate on extracted steady state currents is illustrated for 
comparison (open circles). In this case the broken line represents a fit to 
the data by an arbitrary cubic spline. In each case points represent 
means+S.E, for data obtained from three different cells, except for 
perrhenate at 0.5 mM where results from only two cells have been 
utilised. 
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have indicated that the viral sequence between the initia- 
tion site and the natural polyhedrin ATG (50 base pairs) 
must be preserved for optimal expression [17]. Inclusion of 
the 5' untranslated region (83 base pairs) of clc-1 does not 
interfere with this viral sequence. However, the spacing 
between the transcription initiation site and the ATG is 
reduced from 127 bp in BVDA1 to 32 bp in BVDA6 
constructs. While no definitive studies have been per- 
formed to investigate the effect of spacing between these 
elements, it is possible that keeping the separation close to 
that found naturally in the viral genome may be a factor in 
optimising the transcription and/or translation of foreign 
sequences. Alternatively, and given the experience with 
expression in Xenopus oocytes [4], we favour the view 
that the 5' untranslated region of clc-1 contains some 
cis-acting elements which directly inhibit its transcription 
and/or translation in insect and amphibian cells. 
Although its DNA sequence predicts an unprocessed 
mass of 110 kDa, on PAGE the C1C-1 protein from Sf-9 
cells has an apparent M r of ca. 116 kDa. This might 
reflect its hydrophobic nature, extremely hydrophobic pro- 
teins commonly running at anomalous molecular weights. 
Alternatively, the expressed CIC-1 could have been sub- 
jected to some post-translational processing event(s). For 
example, Kieferle et al. [2] have convincingly demon- 
strated glycosylation of C1C proteins in a mammalian-de- 
rived cell free system. Cultured insect cells are known to 
be capable of performing all post-translational modifica- 
tions performed by mammalian cells, including palmityla- 
tion, acylation and glycosylation, albeit not always authen- 
tically (for review see [12]). Electrophoresis and Western 
blotting of native C1C-1, extracted irectly from rat mus- 
cle, has recently been reported [18]. The native protein also 
migrates with an apparent M r higher than predicted, how- 
ever the authors were unable to determine definitively 
whether or not the protein was glycosylated in vivo. Our 
investigation with tunicamycin suggests that C1C-1 is not 
glycosylated in Sf-9 cells. Furthermore, when compared 
with CIC-1 expressed in HEK293 cells, its electrophysio- 
logical behaviour suggests that, if any processing differ- 
ences exist between these cell lines, then they are inconse- 
quential. 
In agreement with the high level of C1C-1 expression 
indicated by PAGE analysis, patch clamping demonstrates 
the appearance of large, voltage-dependent currents consis- 
tent with the presence of numerous, selective chloride 
channels. These currents are independent of large changes 
in divalent cation concentration and of the absence of Na + 
and K +. Voltage dependence and deactivation and activa- 
tion kinetics of the currents are in good agreement with the 
macroscopic chloride currents found in whole muscle [19] 
as well as being very similar to those found in transfected 
HEK293 cells[9]. Just as for the HEK293 cells, kinetics of 
the currents in Sf-9 cells are faster than those found when 
C1C-1 is expressed in Xenopus oocytes. We have, as yet, 
no mechanistic explanation for the various components of 
deactivation of the inward currents nor for the property of 
inward rectification. Analogies with the inward rectifier 
potassium channel can, however, be drawn, where similar 
current-voltage r lations have been obtained as a result of 
potential-dependent channel block by intracellular Mg 2+ 
and extracellular Cs ÷ [20]. It is also worth noting that a 
volume regulatory C1- channel from cultured human small 
intestine pithelial cells (Intestine 407) displays an appar- 
ent deactivation and block due to intracellular Mg 2÷ [21]. 
Lack of a significant effect when Ca 2÷ and Mg 2+ concen- 
trations were manipulated or when all small cations other 
than H ÷ were substituted by Tris, suggests that this partic- 
ular mechanism is not responsible for similar character- 
istics in C1C-1. 
Stability of the patch-clamp seal in both whole-cell and 
outside-out configurations combined with the longevity of 
recordings makes the Sf-9 preparation ideal for pharmaco- 
logical studies and determination of metabolic ontrol of 
C1C-1. For example, entire dose-response curves and 
washout with return to control conditions are currently 
being performed on the one preparation. Both instanta- 
neous and steady state inward and outward currents are 
blocked by various compounds, e.g., A9C, perrhenate, 
2,4-D and iodide, which are known to block chloride 
conductance in whole muscle. Considering the possibility 
that channel environment and, perhaps, modulatory protein 
subunits could alter the pharmacological behaviour of C1C- 
1, the ICs0 determined for A9C in the present study 
compares well with that determined in rat muscle in situ 
[22] and suggests that any such influences are insubstan- 
tial. Niflumate has not previously been described as a 
blocker of muscle chloride channels although it and the 
related iphenylaminecarboxylates r  well known as chlo- 
ride transport inhibitors in other tissues [23-26]. It is 
possible that the mechanism of block for some of these 
agents is simple occlusion of the channel pore, but for 
others, such as perrhenate where channel kinetics appear to 
be affected, channel gating must be modified. 
The increase in potency of A9C in low chloride solution 
could simply reflect competition between this blocker and 
C1- for a common binding site, implying that A9C exerts 
its action within the channel pore, however alternative 
explanations are also possible. One such explanation would 
be that binding of A9C to a site remote from the pore 
could induce a reversible change in protein conformation 
which destroys one or more chloride binding site. Con- 
versely, when chloride is bound to its site(s) the channel 
may be unable to undergo this A9C induced conforma- 
tional change and/or bound blocker may be displaced. 
Under this scenario an equilibrium between chloride and 
A9C binding would exist which would clearly be shifted in 
favour of the blocker with significantly reduced C1- con- 
centration. An intramembrane site of action for A9C has 
previously been suggested [22]. 
These blockers are active as rapidly as solution change 
can be effected (within seconds). By contrast, IAA94/95 
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added to the bath solution is slow to act and is then poorly 
reversible. A similar time course has been obtained when 
using IAA94/95 on the isolated rat diaphragm to induce 
chloride channel block myotonia (Bretag, A.H., unpub- 
lished observations). These results are consistent with an 
intraceilular site of chloride channel block by IAA94/95, 
for which additional evidence has been presented by We- 
ber-Schiirholz et al. [27], although other interpretations are 
also possible. Altogether our results underline the appro- 
priateness of the Sf-9 system expressing C1C-I as a model 
for the study of the skeletal muscle cell membrane chloride 
conductance and add additional weight to the already 
strong case that CIC-1 comprises the major chloride per- 
meation pathway in these membranes. 
Arginine 304 is highly conserved throughout the C1C 
family. The currently predicted topology of the channel 
places this residue within the cytoplasm at the base of the 
fifth membrane spanning domain, previously designated 
D6 [4]. Reversing the charge of this residue did not 
detectably alter the behaviour of the channel with respect 
to its kinetics, selectivity or sensitivity to the blockers 
tested. These results uggest that this residue, despite being 
highly conserved, oes not participate in the gating process 
and is unlikely to be exposed in the pore of C1C-1. It 
apparently also does not form part of the ligand binding 
site(s) for any of the blocking agents used in this study. 
In cell-attached and outside-out patches, the absence of 
obvious single channel events attributable to C1C-1 con- 
forms with previous studies where a single channel con- 
ductance of the order of 1 pS has been suggested on the 
basis of noise analysis [9]. We are, however, surprised by 
the lack of non-linear currents in any of our cell-attached 
patches (many hundreds) and by the relatively enormous 
currents een in some of our outside-out patches (up to 5% 
of whole cell currents). One explanation for these results 
could be that an interaction with the glass somehow inacti- 
vates CIC-1 channels inside a pipette tip in a cell-attached 
patch. Another could be heterogeneity in distribution of 
C1C-I in the plasmalemma of the Sf-9 cells, with C1C-1 
occurring in extended homogeneous arrays. Gigaohm seals 
might only be possible if the pipette contacts the lipid 
bilayer and not if it contacts uch a protein raft, so that 
channels could never be captured inside a successful cell- 
attached patch. Conversely, outside-out patches could con- 
tain anything from no CIC-1 channels up to an extensive 
raft of them, thus accounting for the variation in the 
observed ensemble current. The dominant negative ffect 
of CIC-1 mutations in Thomsen's autosomal dominant 
myotonia congenita has been ascribed to a multimeric 
(trimeric or tetrameric) association of CIC-1 monomers 
[28]. Alternatively, a protein raft or array could display an 
equivalent dominant negative ffect due to nearest neigh- 
bour interactions between normal and mutant proteins. 
Depending on the type of interaction between monomers, 
on the number of monomers that must cooperate to form a 
single channel and on the type of packing in an array, 
variable proportions of the potential maximum channel 
number could be eliminated by incorporation of defective 
monomers (cf. [29,30]). 
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